Rhythm Pharmaceuticals, Inc. earnings per share and revenue

RYTM earnings per share for the last quarter are -0.72 USD whereas the estimation was -0.69 USD which accounts for -3.81% surprise. Company revenue for the same period amounts to 41.83 M USD despite the estimated figure of 38.48 M USD. Estimated earnings per share for the next quarter are -0.69 USD, and revenue is expected to reach 40.16 M USD. Also watch annual changes over time to get a bigger picture of RYTM earnings per share and revenue dynamics.